Who Owns Enanta Pharmaceuticals Stock?
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 91.49%
- Held by insiders
- 4.67%
- Institutional holders
- 185
- Institutions 91.5%
- Insiders 4.7%
- Public and other 3.8%
Who owns Enanta Pharmaceuticals stock?
Institutional investors own about 91.5% of Enanta Pharmaceuticals's shares, spread across 185 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.67% of ENTA.
The largest institutional holders are Blackrock Inc. (13.33%), Janus Henderson Group Ltd. (12.55%) and Krensavage Asset Management, LLC (9.84%). Together, the top 10 institutions control 63.1% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their ENTA positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ENTA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.88M | 13.33% | +19.7% |
| Janus Henderson Group Ltd. | 3.65M | 12.55% | -3.4% |
| Krensavage Asset Management, LLC | 2.87M | 9.84% | 0.0% |
| Adar1 Capital Management, LLC | 1.73M | 5.95% | +28.9% |
| Vanguard Capital Management LLC | 1.20M | 4.11% | -1.3% |
| Spruce Street Capital LP | 1.09M | 3.74% | 0.0% |
| Acadian Asset Management. LLC | 1.02M | 3.50% | -5.3% |
| Deep Track Capital, Lp | 1.00M | 3.43% | -30.8% |
| Vanguard Portfolio Management LLC | 976.69K | 3.35% | -3.4% |
| Farallon Capital Management LLC | 950.00K | 3.26% | -60.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ENTA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 877.12K | 3.01% |
| iShares Trust-iShares Russell 2000 ETF | 739.62K | 2.54% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 492.00K | 1.69% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 310.20K | 1.07% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 301.26K | 1.03% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | 280.93K | 0.96% |
| iShares Trust-iShares Biotechnology ETF | 215.10K | 0.74% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 180.74K | 0.62% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 162.77K | 0.56% |
| Vanguard Explorer Fund | 140.62K | 0.48% |
Frequently asked questions
Who is the largest shareholder of Enanta Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of ENTA, owning 13.33% of shares outstanding (3.88M shares) as of its latest 13F filing.
What percentage of Enanta Pharmaceuticals is owned by institutions?
Institutions own about 91.5% of ENTA shares and 96.0% of the public float.
How much of Enanta Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 4.67% of ENTA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.